Related Experiment Video
Updated: Aug 5, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
[Analysis of Clinical Features and Gene Mutation in Children with Hereditary Coagulation Factor Deficiency]
Qing-Jie Meng1, Juan You1, Xin Shen1
1Department of Clinical Laboratory Examination,Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, Hubei Province, China.
Objective:
To analyze the clinical features, laboratory tests and gene mutations of children with hereditary coagulation factor deficiency, and explore the correlation between gene mutations and clinical phenotypes.
Methods:
The clinical data of 34 children with hereditary coagulation factor deficiency were reviewed, and high-throughput sequencing was used to detect pathogenic genes.
Results:
Among the 34 children, there were 32 males and 2 females, with a median age of 1.65 years (from 2 days to 11 years). There were 28 cases that had bleeding symptoms, including 11 cases of oral and nasal bleeding, 21 cases of mucocutaneous bleeding, 3 cases of intracranial bleeding, 4 cases of joint bleeding, 3 cases of gastrointestinal bleeding, 6 cases of surgical or traumatic bleeding. Four cases had a family history. Laboratory tests showed significant prolongation of prothrombin time or activated partial thromboplastin time. Among the 25 children with hemophilia A, there were 9 mild cases, 9 moderate cases, and 7 severe cases. There were 4 cases with intron 22 inversion in severe hemophilia A, while mild cases were mainly characterized by missense mutations. There were 4 cases with F Ⅸ gene mutations, 2 cases with F Ⅶ gene mutations, 2 cases with F Ⅺ gene mutations, and 1 case with F Ⅻ mutation. The F Ⅺ variant c.1036T>C (p.C346R) and F Ⅻ variant c.115+2T>A were novel mutations that had not been reported.
Conclusion:
Most patients with hereditary coagulation factor deficiency have a bleeding tendency, and gene test is important for diagnosis and prognostic evaluation of the disease.
Related Concept Videos
Pedigree Analysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
